Judges slam J&J’s ‘reprehensible’ talc defense, cut massive 2018 verdict to $2.11B
For years, Johnson & Johnson has vowed to appeal each talc verdict it lost, and the company cited a “fundamentally unfair process” and “multiple errors” when jurors in St. Louis ordered the company to pay $ 4.69 billion to 22 women with ovarian cancer. Now, an appeals court has reduced that award—but only to $ 2.11 billion, thanks to J&J’s “outrageous” and “reprehensible” defense of the product.… Read More »